Conferences

3–4 October 2016, San Diego, USA
Biomarkers & Precision Medicine USA Congress 2016

Attended by over 200 participants from the pharmaceutical industry, the congress offers a balance of scientific presentations and unprecedented networking opportunities. In line with the current industry trends, day one of the congress focusses on the identification of safety biomarkers, the translation of biomarkers from the discovery to the early development stages as well as personalised healthcare. Expert case studies will also cover insights into novel biomarker discoveries and development in different therapeutic areas such as immune-oncology, CNS diseases, neuroscience & infectious diseases.

The companion diagnostics & personalised medicine stream features the latest updates in companion diagnostics developments, regulatory updates and the future of targeted therapy, precision medicine & patient self-monitoring in healthcare.

http://www.biomarkersusa-congress.com/

Back to TopTop